Treace Medical Concepts I...

7.82
-0.50 (-6.01%)
At close: Apr 03, 2025, 3:59 PM
8.00
2.39%
After-hours: Apr 03, 2025, 07:21 PM EDT

Treace Medical Concepts Statistics

Share Statistics

Treace Medical Concepts has 62.62M shares outstanding. The number of shares has increased by 0.98% in one year.

Shares Outstanding 62.62M
Shares Change (YoY) 0.98%
Shares Change (QoQ) 0.52%
Owned by Institutions (%) 59.93%
Shares Floating 44.91M
Failed to Deliver (FTD) Shares 21
FTD / Avg. Volume 0.01%

Short Selling Information

The latest short interest is 2.27M, so 3.64% of the outstanding shares have been sold short.

Short Interest 2.27M
Short % of Shares Out 3.64%
Short % of Float 5%
Short Ratio (days to cover) 7.98

Valuation Ratios

The PE ratio is -8.29 and the forward PE ratio is -13.53. Treace Medical Concepts's PEG ratio is -0.75.

PE Ratio -8.29
Forward PE -13.53
PS Ratio 2.21
Forward PS 1.6
PB Ratio 4.09
P/FCF Ratio -9.48
PEG Ratio -0.75
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Treace Medical Concepts.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.62, with a Debt / Equity ratio of 0.62.

Current Ratio 4.62
Quick Ratio 3.5
Debt / Equity 0.62
Debt / EBITDA -1.66
Debt / FCF -1.43
Interest Coverage -10.6

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $438.9K
Profits Per Employee $-116.86K
Employee Count 477
Asset Turnover 0.96
Inventory Turnover 1.05

Taxes

Income Tax 0
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by -32.14% in the last 52 weeks. The beta is 0.78, so Treace Medical Concepts's price volatility has been higher than the market average.

Beta 0.78
52-Week Price Change -32.14%
50-Day Moving Average 9.17
200-Day Moving Average 7.28
Relative Strength Index (RSI) 44.78
Average Volume (20 Days) 407.21K

Income Statement

In the last 12 months, Treace Medical Concepts had revenue of 209.36M and earned -55.74M in profits. Earnings per share was -0.9.

Revenue 209.36M
Gross Profit 168.26M
Operating Income -55.69M
Net Income -55.74M
EBITDA -42.07M
EBIT -50.49M
Earnings Per Share (EPS) -0.9
Full Income Statement

Balance Sheet

The company has 11.35M in cash and 69.65M in debt, giving a net cash position of -58.3M.

Cash & Cash Equivalents 11.35M
Total Debt 69.65M
Net Cash -58.3M
Retained Earnings -189.99M
Total Assets 217.09M
Working Capital 126.48M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -37.17M and capital expenditures -11.59M, giving a free cash flow of -48.76M.

Operating Cash Flow -37.17M
Capital Expenditures -11.59M
Free Cash Flow -48.76M
FCF Per Share -0.79
Full Cash Flow Statement

Margins

Gross margin is 80.37%, with operating and profit margins of -26.6% and -26.63%.

Gross Margin 80.37%
Operating Margin -26.6%
Pretax Margin -26.63%
Profit Margin -26.63%
EBITDA Margin -20.09%
EBIT Margin -26.6%
FCF Margin -23.29%

Dividends & Yields

TMCI does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for TMCI is $8, which is -3.8% lower than the current price. The consensus rating is "Hold".

Price Target $8
Price Target Difference -3.8%
Analyst Consensus Hold
Analyst Count 7
Stock Forecasts

Scores

Altman Z-Score 2.7
Piotroski F-Score 3